Adjuvant interferon-alpha in malignant melanoma: current status
- 30 April 2000
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 26 (2) , 81-89
- https://doi.org/10.1053/ctrv.1999.0163
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Randomized Trial of Adjuvant Human Interferon Gamma Versus Observation in High-Risk Cutaneous Melanoma: a Southwest Oncology Group StudyJNCI Journal of the National Cancer Institute, 1995
- Phase II Study of Recombinant α-Interferon in Malignant MelanomaAmerican Journal of Clinical Oncology, 1990
- Comparison of the effects of three different treatment regimens of recombinant interferons (r-IFN ?, r-IFN ?, and r-IFN ? +cimetidine) in disseminated malignant melanomaZeitschrift für Krebsforschung und Klinische Onkologie, 1987
- Phase II trial of recombinant leukocyte A interferon in advanced malignant melanomaZeitschrift für Krebsforschung und Klinische Onkologie, 1987
- Three consecutive phase II studies of recombinant interferon alfa–2a in advanced malignant melanoma. Updated analysesCancer, 1987
- Treatment of Metastatic Malignant Melanoma with Recombinant Interferon Alpha 2Immunobiology, 1986
- Phase-II Study of Recombinant α2-Interferon in Advanced Malignant MelanomaJournal of Interferon Research, 1986
- Comparison of Intramuscular and Intravenous Recombinant Alpha-2 Interferon in Melanoma and Other CancersAnnals of Internal Medicine, 1985
- Effects of recombinant leukocyte interferon (rIFN-α A) on tumour growth and immune responses in patients with metastatic melanomaBritish Journal of Cancer, 1985
- Phase II study of recombinant leukocyte a interferon (rIFN-αA) in disseminated malignant melanomaCancer, 1984